Overview
This webinar will feature two presentations and will be followed by a question and answer session.
In this session, the faculty will:
- review the concept of the oligometastatic state.
- discuss new evidence assessing the role of stereotactic radiation, and other ablative therapies, in the treatment of oligometastatic NSCLC.
- provide a practical approach to managing patients with oligometastases;
- examine possible combinations of radiation with targeted agents and/or immunotherapy, in patients with oligometastases.
After viewing this webinar, attendees will be able to:
- describe the current status of SBRT for the treatment of oligometases.
- identify novel treatment recommendations for the management of patients with oligometastases.
- illustrate current clinical trials enrolling patients with oligometastatic disease.
Program Chair: Laurie E. Gaspar, MD, FASTRO, FACR, MBA
Grohne Chair in Clinical Oncology, Department of Radiation Oncology,University of Colorado School of Medicine Denver, Colorado USA.
Joe Y. Chang, MD, PhD
Professor and Clinical Section, Chief of Thoracic Radiation Oncology, UT MD Anderson Cancer Center, USA.
Dr. David Palma, MD, MSc, FRCPC, PhD
Radiation Oncologist, London Health Sciences Centre, Clinician-Scientist, Ontario Institute for Cancer Research.
For any inquiries, please contact meetings@iaslc.org.
After viewing this webinar, attendees will be able to:
- describe the current status of SBRT for the treatment of oligometases.
- identify novel treatment recommendations for the management of patients with oligometastases.
- illustrate current clinical trials enrolling patients with oligometastatic disease.
Program Chair: Laurie E. Gaspar, MD, FASTRO, FACR, MBA
Grohne Chair in Clinical Oncology, Department of Radiation Oncology,University of Colorado School of Medicine Denver, Colorado USA.
Joe Y. Chang, MD, PhD
Professor and Clinical Section, Chief of Thoracic Radiation Oncology, UT MD Anderson Cancer Center, USA.
Dr. David Palma, MD, MSc, FRCPC, PhD
Radiation Oncologist, London Health Sciences Centre, Clinician-Scientist, Ontario Institute for Cancer Research.
For any inquiries, please contact meetings@iaslc.org.